John Talbot BPharm, MSc,PhD

John Talbot, Senior Lecturer, Pharmacovigilance, University of Hertfordshire Dr John Talbot BPharm MSc PhD is Senior Lecturer, Pharmacovigilance within the School of Life & Medical Sciences at the University of Hertfordshire. Until mid-2011 he was Director Patient Safety, Processes & Standards and Deputy QPPV, based at AstraZeneca R&D Charnwood in Loughborough UK. John had been with AstraZeneca since 1996 initially leading the Drug Safety function at one of its R&D sites and later having a global role encompassing Patient Safety processes and standards across the organisation.

He was a hospital pharmacist at a number of UK teaching hospitals and held a joint appointment at the Department of Therapeutics in the University of Birmingham Medical School and the Queen Elizabeth Hospital where he did his PhD on adverse drug reaction monitoring. He has written papers and book chapters on various aspects of drug safety. He is co-editor with Jeff Aronson of Stephens’ Detection and Evaluation of Adverse Drug Reactions 6th edition published by Wiley Blackwell in early 2012. Over the past 25 years, he has made many presentations at universities and international symposia on several drug safety topics and helped create the postgraduate course in Pharmacovigilance at the University of Hertfordshire.